Birkneh Tilahun Tadesse
1
* , MD, PhD ;
Farhana Khanam
2
* , MBBS ;
Faisal Ahmmed
2
, MSc ;
Xinxue Liu
3
, PhD ;
Md Taufiqul Islam
2
, MBBS ;
Deok Ryun Kim
1
, PhD ;
Sophie SY Kang
1
, MSc ;
Justin Im
1
, PhD ;
Fahima Chowdhury
2
, MBBS ;
Tasnuva Ahmed
2
, MBBS ;
Asma Binte Aziz
1
, MBBS ;
Masuma Hoque
2
, MBBS ;
Juyeon Park
1
, MSc ;
Gideok Pak
1
, MSc ;
Hyon Jin Jeon
1
, MSc ;
Khalequ Zaman
2
, PhD ;
Ashraful Islam Khan
2
, PhD ;
Jerome H Kim
1
, MD ;
Florian Marks
1, 4, 5
, PhD ;
Firdausi Qadri
2
, PhD ;
John D Clemens
1, 2
, MD
1
Epidemiology, Public Health, Impact Unit, International Vaccine Institute, Seoul, Republic of Korea
2
Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
3
Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom
4
Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
5
Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar
*these authors contributed equally
Corresponding Author:
-
Birkneh Tilahun Tadesse, MD, PhD
-
Epidemiology, Public Health, Impact Unit
-
International Vaccine Institute
-
SNU Research Park
-
1 Gwanak-ro, Gwanak-gu
-
Seoul, 08826
-
Republic of Korea
-
Phone:
82 1098041348
-
Email: birkneh.tadesse@ivi.int